Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-139-7 | CAS number: 103-73-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity:
The acute oral toxicity dose (LD50) was considered based on different studies conducted on rats, mice and guinea pigs for the test chemical. The LD50 value is 2200 mg/kg bw. The study concluded that LD50 value is >2000 mg/kg bw, for acute oral toxicity. Thus, comparing this value with the criteria of CLP regulation, the given test chemical cannot be classified for acute oral toxicity.
Acute Inhalation Toxicity:
The acute inhalation toxicity dose (LC50) was considered based on different studies conducted on rats for the test chemical. The studies concluded that LC50 value is 8949 mg/m3. The study concluded that LC50 value is >5 mg/L, for acute inhalation toxicity. Thus, comparing this value with the criteria of CLP regulation, the given test chemical cannot be classified for acute inhalation toxicity.
Acute Dermal toxicity:
The acute dermal toxicity dose (LD50) was considered based on different studies conducted on rats and rabbits for the test chemical. The studies concluded that LD50 value is 5000 mg/kg bw. The study concluded that LD50 value is >2000 mg/kg bw, for acute dermal toxicity. Thus, comparing this value with the criteria of CLP regulation, the given test chemical cannot be classified for acute dermal toxicity.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- The toxicity and toxic manifestations of phenetole(as influenced bt chemical changes in DDT) in mice.
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Species:
- mouse
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source:Not available
- Age at study initiation:Not available
- Weight at study initiation:20-30 gm
- Fasting period before study:Not available
- Housing:individual cages
- Diet (e.g. ad libitum):Purina dog chow(ad libitum)
- Water (e.g. ad libitum):water(ad libitum)
- Acclimation period:Not available
ENVIRONMENTAL CONDITIONS
- Temperature (°C):Not available
- Humidity (%):Not available
- Air changes (per hr):Not available
- Photoperiod (hrs dark / hrs light):Not available
IN-LIFE DATES: From: To: - Route of administration:
- oral: gavage
- Vehicle:
- olive oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle:5,10 or 25 percent solutions in olive oil
- Amount of vehicle (if gavage):Not available
- Justification for choice of vehicle:Not available
- Lot/batch no. (if required):Not available
- Purity:Not available
MAXIMUM DOSE VOLUME APPLIED:Not applicable
DOSAGE PREPARATION (if unusual):5,10 or 25 percent solutions in olive oil
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose:Not available - Doses:
- 1200,1400,1600,1800,2000 & 2200 mg/kg
- No. of animals per sex per dose:
- 1200mg/kg-10
1400mg/kg-10
1600mg/kg-10
1800mg/kg-10
2000mg/kg-10
2200mg/kg-10 - Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 7 days
- Frequency of observations and weighing:no data
- Necropsy of survivors performed: no data
- Other examinations performed: clinical signs-incidence of tremors,convulsions & fatalities noted - Statistics:
- Not availble
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 2 200 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: 50 percent mortality observed
- Mortality:
- 50 percent mortality observed at 2200 mg/kg,whereas 80 percent mortality was seen at dose 2000 mg/kg and 10 percent mortality was seen at 1600 & 1800 mg/kg respectively.
- Clinical signs:
- other: Shortly after the administration the animals became depressed and with larger doses they passed into deep necrosis in 2-3 hrs and majority of animals died in a comatose condtion within 1-2 days.
- Gross pathology:
- Not available
- Other findings:
- Not available
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute oral median lethal dose (LD50) of phenetole in mouse was found to be 2200 mg/kg of body weight as 50 percent mortality was observed at this dose.
- Executive summary:
In the study the acute oral toxicity of test compound was determined in white mice by orally administering the test compound in olive oil at doses 1200, 1400,1600,1800,2000 & 2200 mg/kg and observed for clinical signs and mortality for 1 week. The acute oral median lethal dose (LD50) of test chemical in mouse was found to be 2200 mg/kg of body weight (50 percent mortality observed), 80 percent mortality was seen at dose 2000 mg/kg and 10 percent mortality was seen at 1600 & 1800 mg/kg respectively. Thus considering the CLP criteria for classification it can be assessed that the given test chemical is non toxic via oral route as it exceeds the criteria of 2000 mg/kg bw for the substance to be classified as toxic.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 200 mg/kg bw
- Quality of whole database:
- Data is Klimisch 2 and from publication.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Qualifier:
- according to guideline
- Guideline:
- other:
- Principles of method if other than guideline:
- standard acute method
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Route of administration:
- inhalation
- Type of inhalation exposure:
- not specified
- Vehicle:
- not specified
- Duration of exposure:
- 2 h
- Control animals:
- not specified
- Sex:
- not specified
- Dose descriptor:
- LC50
- Effect level:
- 8 949 mg/m³ air
- Based on:
- test mat.
- Exp. duration:
- 2 h
- Remarks on result:
- other: other details not available
- Mortality:
- Lethal concentration, 50 percent kill
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The 2hr.acute inhalation median lethal concentration (LC50) of anisole in rat was found to be 8949 mg/m3. Acute inhalation toxicity of anisole to rat by inhalative route indicates that the substance does not exhibits acute toxicity by the inhalative route.
- Executive summary:
The 2hr.acute inhalation median lethal concentration (LC50) of anisole in rat was found to be 8949 mg/m3. Acute inhalation toxicity of anisole to rat by inhalative route indicates that the substance does not exhibits acute toxicity by the inhalative route.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 8 949 mg/m³ air
- Quality of whole database:
- Data is from secondary source.
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Not available
- GLP compliance:
- not specified
- Test type:
- other: No data
- Species:
- rabbit
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- Not available
- Type of coverage:
- not specified
- Vehicle:
- not specified
- Details on dermal exposure:
- Details not available
- Duration of exposure:
- Details not available
- Doses:
- Details not available
- No. of animals per sex per dose:
- Details not available
- Control animals:
- not specified
- Details on study design:
- Details not available
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Non toxic
- Mortality:
- Details not available
- Clinical signs:
- other: Details not available
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- A dermal LD50 study was conducted in which 5000 mg/kg of Anisole was applied to the skin of rabbits. The animals were observed for mortality and/or systemic effects for 14 days. No further details were provided. Acute dermal LD50/rabbits > 5000 mg/kg bw was determined.
- Executive summary:
A dermal LD50 study was conducted in which 5000 mg/kg of Anisole was applied to the skin of rabbits. The animals were observed for mortality and/or systemic effects for 14 days. No further details were provided. Acute dermal LD50/rabbits > 5000 mg/kg bw was determined.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- Data is Klimisch 2 and from publication.
Additional information
Acute oral toxicity:
In different studies, the given test chemical has been investigated for acute oral toxicity to a greater or lesser extent. Often are the studies based on in-vivo experiments in rodents, i.e. most commonly in rats, mice and guinea pigs for test chemical. The studies are summarized as below –
1. In the study the acute oral toxicity of test compound was determined in white mice by orally administering the test compound in olive oil at doses 1200, 1400,1600,1800,2000 & 2200 mg/kg and observed for clinical signs and mortality for 1 week. The acute oral median lethal dose (LD50) of test chemical in mouse was found to be 2200 mg/kg of body weight (50 percent mortality observed), 80 percent mortality was seen at dose 2000 mg/kg and 10 percent mortality was seen at 1600 & 1800 mg/kg respectively. Thus considering the CLP criteria for classification it can be assessed that the given test chemical is non toxic via oral route as it exceeds the criteria of 2000 mg/kg bw for the substance to be classified as toxic.
2. The acute oral median lethal dose (LD50) of the given test chemical in guinea pig was found to be 3000 mg/kg of body weight. Thus considering the CLP criteria for classification of the substance it can be assessed that the substance does not exhibits acute toxicity by the oral route as it exceeds the criteria of 2000 mg/kg bw for the substance to be classified as toxic.
3. The purpose of this study was to evaluate the toxicity of Anisole on Osborne-Mendel rats. Osborne-Mendel rats were given ionone undiluted at dose of 3700 (3240-4200) mg/kg and observed for 2 weeks for signs of toxicity and mortality. The LD50 value obtained was at 3700 ( (3240-4200) mg/kg with rats showing depression, porphyrin like deposit around eyes, salvation, bloody urine, rough fur. and mortality was observed 4hrs - 8days. From this value it is concluded that the substance Anisole is not toxic to Osborne-Mendel rat by oral route.
4. The assay was conducted to select dose levels for the cytogenetic test. Groups of rats (5/sex/dose) were treated with various dose levels (5000, 2500, 1250, and 625 mg/kg bw) of the test material. The survival of the treated rats was monitored for the next 14 days. Based upon the pattern of mortality, LD50 values of 2937 mg/kg and 4013 mg/kg were estimated for males and females, respectively, by the moving average method.
Thus, based on the above summarised studies on test chemical, it can be concluded that LD50 value is >2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, the given test chemical cannot be classified for acute oral toxicity.
Acute Inhalation Toxicity:
In different studies, the given test chemical has been investigated for acute inhalation toxicity to a greater or lesser extent. Often are the studies based on in-vivo experiments in rodents, i.e. most commonly in rats for test chemical. The studies are summarized as below-
1. The 2hr.acute inhalation median lethal concentration (LC50) of anisole in rat was found to be 8949 mg/m3. Acute inhalation toxicity of anisole to rat by inhalative route indicates that the substance does not exhibits acute toxicity by the inhalative route.
2. The acute inhalation median lethal concentration (LC50) of anisole in rat was found to be >5000 mg/m3. Acute inhalation toxicity of anisole to rat by inhalative route indicates that the substance does not exhibits acute toxicity by the inhalative route.
Thus, based on the above summarised studies on test chemical, it can be concluded that LC50 value is >5 mg/L. Thus, comparing this value with the criteria of CLP regulation, the given test chemical cannot be classified for acute inhalation toxicity.
Acute Dermal Toxicity:
In different studies, the given test chemical has been investigated for acute dermal toxicity to a greater or lesser extent. Often are the studies based on in-vivo experiments in rodents, i.e. most commonly in rats and rabbits for test chemical. The studies are summarized as below –
1. The test substance was held in continuous 24-hour contact with the shaved skin at the dose level 5.0 ml/kg,2.5ml/kg and 1.25 ml/kg and observed for 14 days. Signs of intoxication were reported as diarrhoea and depression with skin irritation and Eschar formation was observed. LD50 value was assessed to be 2.03 ml/kg (2030 mg/kg).Considering the CLP criteria for classification of the substance the LD 50 value is more than the threshold of 2000 mg/kg for the substance to qualify as toxic. Hence the test chemical was found to be non toxic to rabbit via dermal route.
2. The test substance was applied to the dorsolumbar region under an occlusive patch; so that 10% of the body surface was covered test material remained in contact with the skin for 24 hours. Five rats per dose were tested. Doses ranged from 1-22.2 ml/kg bw was applied. Hemorrhagic lungs were found at necropsy. The LD50 value (and 95% confidence limits) was calculated to be 13.0 (10.3 to 15.4) ml/kg bw((14.3 g/kg or 14300 mg/kg) based on a density of 1.1 g/ml.
3. A dermal LD50 study was conducted in which 5000 mg/kg of Anisole was applied to the skin of rabbits. The animals were observed for mortality and/or systemic effects for 14 days. No further details were provided. Acute dermal LD50/rabbits > 5000 mg/kg bw was determined.
Thus, based on the above summarised studies on test chemical, it can be concluded that LD50 value is >2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, the given test chemical cannot be classified for acute dermal toxicity.
Justification for classification or non-classification
Based on the above studies on test chemical, it can be concluded that LD50 value is >2000 mg/kg bw, for acute oral and acute dermal toxicity; and LC50 value is >5 mg/L (>5000 mg/m3). Thus, comparing this value with the criteria of CLP regulation, the given test chemical cannot be classified for acute oral, acute inhalation and acute dermal toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.